Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Core Laboratories (CLB) Gross Margin (2022 - 2026)

Core Laboratories filings provide 5 years of Gross Margin readings, the most recent being 78.69% for Q1 2026.

  • On a quarterly basis, Gross Margin rose 12.0% to 78.69% in Q1 2026 year-over-year; TTM through Mar 2026 was 33.95%, a 2680.0% decrease, with the full-year FY2025 number at 42.6%, down 64.0% from a year prior.
  • Gross Margin hit 78.69% in Q1 2026 for Core Laboratories, up from 56.28% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 166.85% in Q4 2022 to a low of 56.28% in Q4 2025.
  • Median Gross Margin over the past 5 years was 76.29% (2023), compared with a mean of 68.09%.
  • Biggest five-year swings in Gross Margin: surged 281bps in 2023 and later plummeted -9969bps in 2025.
  • Core Laboratories' Gross Margin stood at 166.85% in 2022, then crashed by -54bps to 76.28% in 2023, then tumbled by -43bps to 43.41% in 2024, then plummeted by -230bps to 56.28% in 2025, then skyrocketed by 240bps to 78.69% in 2026.
  • The last three reported values for Gross Margin were 78.69% (Q1 2026), 56.28% (Q4 2025), and 44.32% (Q3 2025) per Business Quant data.